Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.

Jing HeZiwei ChenQingfeng XuePingping SunYuan WangCindy ZhuWenyu Shi

Published in: Journal of translational medicine (2022)

The molecular subtypes and a risk model based on MAGs proposed in our study are both promising prognostic classifications in DLBCL, which may provide novel insights for developing accurate targeted cancer therapies.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
single molecule
copy number
cancer therapy
gene expression
drug delivery
young adults
childhood cancer
genome wide analysis